As of 2024-12-15, the Relative Valuation of Vir Biotechnology Inc (VIR) is (86.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.45 USD, the upside of Vir Biotechnology Inc based on Relative Valuation is -1259.2%.
The range of the Relative Valuation is (83.57) - (94.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 28.9x | 22.3x |
| Forward P/E multiples | 20.0x - 24.3x | 22.3x |
| Fair Price | (83.57) - (94.11) | (86.36) |
| Upside | -1221.8% - -1363.2% | -1259.2% |
| Date | P/E |
| 2024-12-13 | -1.92 |
| 2024-12-12 | -1.92 |
| 2024-12-11 | -2.02 |
| 2024-12-10 | -2.09 |
| 2024-12-09 | -2.25 |
| 2024-12-06 | -2.16 |
| 2024-12-05 | -2.06 |
| 2024-12-04 | -2.16 |
| 2024-12-03 | -2.38 |
| 2024-12-02 | -2.10 |
| 2024-11-29 | -2.06 |
| 2024-11-27 | -2.03 |
| 2024-11-26 | -1.97 |
| 2024-11-25 | -1.92 |
| 2024-11-22 | -1.84 |
| 2024-11-21 | -1.79 |
| 2024-11-20 | -1.74 |
| 2024-11-19 | -1.79 |
| 2024-11-18 | -1.82 |
| 2024-11-15 | -2.07 |
| 2024-11-14 | -2.23 |
| 2024-11-13 | -2.32 |
| 2024-11-12 | -2.39 |
| 2024-11-11 | -2.55 |
| 2024-11-08 | -2.48 |
| 2024-11-07 | -2.52 |
| 2024-11-06 | -2.63 |
| 2024-11-05 | -2.49 |
| 2024-11-04 | -2.42 |
| 2024-11-01 | -2.39 |
| 2024-10-31 | -1.93 |
| 2024-10-30 | -1.96 |
| 2024-10-29 | -1.97 |
| 2024-10-28 | -2.00 |
| 2024-10-25 | -1.93 |
| 2024-10-24 | -1.90 |
| 2024-10-23 | -1.94 |
| 2024-10-22 | -1.97 |
| 2024-10-21 | -1.98 |
| 2024-10-18 | -1.97 |
| 2024-10-17 | -1.99 |
| 2024-10-16 | -2.03 |
| 2024-10-15 | -2.00 |
| 2024-10-14 | -1.98 |
| 2024-10-11 | -1.96 |
| 2024-10-10 | -1.90 |
| 2024-10-09 | -1.89 |
| 2024-10-08 | -1.89 |
| 2024-10-07 | -1.91 |
| 2024-10-04 | -2.00 |